CClinicalTrials.gg
CompletedNCT03480204Updated Feb 19, 2019

Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY

An observational study in Cardiac Arrhythmia, sponsored by The Cleveland Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-19.

Sponsored by The Cleveland Clinic · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the feasibility and usability of a wearable patch as a cardiac monitor for non-ICU hospitalized patients.

Read the detailed description

This study evaluates the feasibility and usability of a wearable patch cardiac monitor, gateway and server concomitant with standard-of-care cardiac telemetry monitoring for non-ICU hospitalized patients on a selected nursing ward at the Cleveland Clinic Heart and Vascular Institute. All patients will receive routine clinical care on the basis of the traditional telemetry monitoring using the usual processes. The patch monitor data will not be reviewed in real-time, and only analyzed post hoc for agreement with the standard-of-care.

02

Conditions studied

  • Cardiac Arrhythmia

Browse trials for

Keywords

  • Telemetry, Patch Monitor, Alarm Fatigue
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Non-ICU hospitalized patients on the J8-3 nursing ward at the Cleveland Clinic Heart and Vascular Institute

Inclusion criteria

  • >= 18 years old and able to provide informed consent
  • Standard indication for cardiac telemetry monitoring (institutional standardized criteria) with valid electronic order

Exclusion criteria

Exclusion Criteria:

  • Cardiac implantable device (pacemaker or ICD)
  • Contact precautions or isolation
  • Telemetry discontinuation planned within 12 hours (i.e. anticipated discharge)
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Connectivity

    Successful patch application by nursing, and transmission of cardiac waveform data to gateway and then to offline secure server

    Time frame: 48 hours

  2. Continuity

    Loss of cardiac waveform signal from patch compared with traditional telemetry monitor.

    Time frame: 48 hours

Secondary outcomes

  1. Agreement for cardiac arrhythmia detection (post hoc, offline)

    Analysis of cardiac arrhythmia detections on patch compared with traditional telemetry for agreement, concordance and discordance.

    Time frame: 48 hours

  2. Body temperature (post hoc, offline)

    Body temperature recorded by patch compared with nursing documentation in a post hoc analysis. Data from patch will not be assessed for patient care in real time.

    Time frame: 48 hours

  3. Cardiac waveform (post hoc, offline)

    Pre-specified analysis of cardiac waveform characteristics in association with pre-specified clinical events such as deployment of emergency response team.

    Time frame: 48 hours

06

Study locations

1 site
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
07

Registry details

Key details

Study ID
NCT03480204
Lead sponsor
The Cleveland Clinic
Collaborators
Isansys Lifecare LTD
Responsible party
Dan Cantillon (Principal Investigator, The Cleveland Clinic) — Principal investigator
First posted
Mar 29, 2018
Start date
Mar 19, 2018
Primary completion
Dec 23, 2018
Completion
Dec 23, 2018
Last update
Feb 19, 2019

Study contacts

Daniel J Cantillon, MD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion